Partnering

With global biomedical innovation moving at an unparalleled pace，partnering fuels scientific progress and patient care.At Novartis，we're collaborating with innovators to address some of society's most challenging healthcare issues。

>50%

外部压力

~130

countries where Novartis products are sold

8.6bn

invested in R&D in 2023（USD）

Partnering focus areas

We are an innovative medicines focused company working on four therapeutic areas and five technology platforms。

Therapeutic Areas

Partnering-Cardiovascular，renal&metabolic

Our efforts include use of early interventions and development of pioneering treatments，from prevention to management，as well as the creation of innovative access models.Our goal is to reduce and ultimature stop premature death and disability from cardiovascular disease。

Learn more

Partnering-Immunology

We focus on discovering and developing transformative therapies，including small molecules and biotherapeutics that target the root cause of these diseases by modulating the immune system to restore health。

Learn more

Partnering-Nouroscience

We look to deliver life-changing solutions and treatments that address the underlying cause of neurodegenerative，neurodevelopmental and neuromuscular diseases to dramatically improve the lives of patients。

Learn more

Partnering-Oncology

We are committed to developing new therapeutic approaches that offer the potential of changing future treatment paradigms and patient journeys therapies for a range of common and rare cancers。

Learn more

Technology Platforms

Partnering-Chemistry

We aim to discover and develop breakthrough molecules by boldly enabling unprecedented biological space with suitably crafted compounds across diverse chemical modalities。

Learn more

Partnering-Biotherapeutics

We strive to leverage cutting-edge science and technology to create novel biotherapeutics that deliver transformative impact in healthcare，and we are dedicated to advancing the production of high-quality biologics，with the goal of ultimately bringsafe and effective treatments to patients in need。

Learn more

Partnering-xRNA

At Novartis，we are pursuing innovative and ground-breaking therapies designed to target RNA and silence disease-causing genes inside cells。

Learn more

Partnering-Radioligand therapy

We are committed to reimagining cancer care by pushing the boundaries of innovation with bold science，like targeted radioligand therapy（RLT）for patients with advanced cancers。

Learn more

Partnering-Call and gene therapy

We are pioneers on the cell and gene therapy frontier，working at the edge of possibility with emerging tools to bring entirely new types of treatments to patients with devastating diseases，including genetic disorders and certain deadly cancers。

Learn more

外部区域，外部区域

In addition to our areas of focus，Novartis also looks to partner in other disease，research and technology areas。

Learn more

Partnering is at the core of our business

We collaborate to address some of society's most challenging healthcare issues and have a unified partnering strategy fueled by clarity，agility，accountability，and efficiency。

See our approach

发现，发现

Large crowd in an auditorium on Basel campus

Where to meet us

See which events Novartis will be attending

Leadership team

Get to know the Corporate&Business Development team

Our approach

发现how we collaborate to address some of society smost challenging healthcare issues

企业开发

外部压力

countries where Novartis products are sold

invested in R&D in 2023（USD）

Partnering focus areas

Therapeutic Areas

Partnering-Cardiovascular，renal&metabolic

Our efforts include use of early interventions and development of pioneering treatments，from prevention to management，as well as the creation of innovative access models.Our goal is to reduce and ultimature stop premature death and disability from cardiovascular disease。

Partnering-Immunology

We focus on discovering and developing transformative therapies，including small molecules and biotherapeutics that target the root cause of these diseases by modulating the immune system to restore health。

Partnering-Nouroscience

We look to deliver life-changing solutions and treatments that address the underlying cause of neurodegenerative，neurodevelopmental and neuromuscular diseases to dramatically improve the lives of patients。

Partnering-Oncology

We are committed to developing new therapeutic approaches that offer the potential of changing future treatment paradigms and patient journeys therapies for a range of common and rare cancers。

Technology Platforms

Partnering-Chemistry

We aim to discover and develop breakthrough molecules by boldly enabling unprecedented biological space with suitably crafted compounds across diverse chemical modalities。

Partnering-Biotherapeutics

Partnering-xRNA

At Novartis，we are pursuing innovative and ground-breaking therapies designed to target RNA and silence disease-causing genes inside cells。

Partnering-Radioligand therapy

We are committed to reimagining cancer care by pushing the boundaries of innovation with bold science，like targeted radioligand therapy（RLT）for patients with advanced cancers。

Partnering-Call and gene therapy

We are pioneers on the cell and gene therapy frontier，working at the edge of possibility with emerging tools to bring entirely new types of treatments to patients with devastating diseases，including genetic disorders and certain deadly cancers。

外部区域，外部区域

Partnering is at the core of our business

获取，获取

发现，发现

Where to meet us

Leadership team

Our approach